Form 4: Teladoc Director Kenneth Paulus Receives Equity Grant

Teladoc Health director Kenneth H. Paulus was granted 30,441 restricted stock units as part of his director compensation.

Summary

• Director Kenneth H. Paulus acquired 30,441 restricted stock units (RSUs) on May 21, 2026.
• Each RSU represents a contingent right to receive one share of Teladoc Health (TDOC) common stock.
• The grant was issued at a price of $0 per share as part of standard director compensation.
• The RSUs are scheduled to vest in full on the earlier of May 21, 2027, or the day before the 2027 annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation that carries no significant signal regarding company performance or outlook.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Potential for future dilution of existing shareholders upon the eventual vesting and issuance of the underlying common stock.

Risks

• Market volatility affecting the future value of the equity grant.
• Dependence on the company's ability to maintain stock performance to ensure the value of director compensation.

Future Outlook

The RSUs will vest in one year, subject to the director's continued service or specific triggering events like a change of control or separation of service.

Industry Context

StockSavvy.ai notes that equity-based compensation for non-employee directors is a standard corporate governance practice in the healthcare technology sector to ensure board members are incentivized to drive long-term company performance.

Comparison to Industry Standards

• The use of RSU grants for board members is consistent with compensation structures at peer digital health companies like Hims & Hers and Amwell.
• The one-year vesting schedule is standard practice for annual director equity awards.

Corporate Governance

Stakeholder Impact

• Shareholders: Minor potential dilution upon future vesting.
• Director: Increased equity stake in the company.

Next Steps

• Vesting of the 30,441 RSUs on May 21, 2027.

Key Dates

Keywords

Teladoc Health, TDOC, Form 4, Insider Trading, Director Compensation, Restricted Stock Units